<?xml version="1.0" ?>
<document version="1.8" entity_encoding="single">
  <page number="1">
    <text>**Endocrine Disease and Dentistry**

by **Dr David Lim**

04 Aug 2026 (Tuesday) 10-11am</text>
    <formatted_text>*by Dr David Lim*

04 Aug 2026 (Tuesday) 10–11am</formatted_text>
  </page>
  <page number="2">
    <text>IMPT!

# Learning Objectives

1. Discuss the specific characteristics and dental needs of individuals with common endocrine conditions (e.g. diabetes, adrenal insufficiency, thyroid disorders)
2. Perform a risk assessment and make appropriate treatment adaptations to ensure safe and effective dental care.
3. Manage diabetic emergencies (hypoglycaemia and hyperglycaemia) in dental practice
4. Review the side-effects of corticosteroids and manage patients at risk of adrenal crisis in dental practice

ADC: 5.1
iADH: 5A, 5B, 5C, 6Ci
Scientific and Clinical Knowledge
5.1
apply the social, cultural, biological, biomedical, physical and behavioural sciences in relation to oral health care provision and disease prevention</text>
    <formatted_text>1. Discuss the specific characteristics and dental needs of individuals with common endocrine conditions (e.g. diabetes, adrenal insufficiency, thyroid disorders)
2. Perform a risk assessment and make appropriate treatment adaptations to ensure safe and effective dental care.
3. Manage diabetic emergencies (hypoglycaemia and hyperglycaemia) in dental practice
4. Review the side-effects of corticosteroids and manage patients at risk of adrenal crisis in dental practice

#### Competency Mapping

- ADC: 5.1
- iADH: 5A, 5B, 5C, 6Ci

Scientific and Clinical Knowledge

5.1 — apply the social, cultural, biological, biomedical, physical and behavioural sciences in relation to oral health care provision and disease prevention</formatted_text>
  </page>
  <page number="3">
    <text>
Hypothalamus,
Pituitary gland

Pineal gland

Thyroid gland

Thymus

Pancreas

Adrenal gland

Testicle

Ovaries

WHAT IS IT ABOUT XXX DISEASE/
CONDITION?
• Definition
• Aetiology
• Epidemiology
• General Manifestations/Clinical 
Features
• General Management/Treatment
• Oral Manifestations
• Oral Management = Risk 
Assessment and ACCESS acronym

![The endocrine system](L6 Endocrine notes_figures/img_a460de3bdd8d63a6.webp)
![The endocrine system](L6 Endocrine notes_figures/img_50f99c4302283276.webp)</text>
    <formatted_text>Major endocrine glands:

- Hypothalamus
- Pituitary gland
- Pineal gland
- Thyroid gland
- Thymus
- Pancreas
- Adrenal gland
- Testicle
- Ovaries

For any disease or condition, consider:

- Definition
- Aetiology
- Epidemiology
- General Manifestations/Clinical Features
- General Management/Treatment
- Oral Manifestations
- Oral Management = Risk Assessment and ACCESS acronym</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:20:43" confidence="3" anchor="#### **Competency Mapping**

- ADC: 5.1
- iADH: 5A, 5B, 5C, 6Ci">
- ==Assess patients with endocrine disease before dental treatment.==
- ==Identify risks associated with diabetes, adrenal insufficiency, thyroid disorders and corticosteroid therapy.==
- ==Adapt dental treatment, surgical planning, prescribing and emergency management to individual patient needs.==</insert>
      <insert timestamp="00:01:34" confidence="5" anchor="- General Management/Treatment
- Oral Manifestations
- Oral Management = Risk As">

&gt; [!note] Lecturer — Endocrine Signaling
&gt; Hormones are biochemical substances that generally act at sites distant from where they are secreted.
&gt; - Pituitary hormones may act on reproductive organs or on the adrenal glands above the kidneys.
&gt; - Endocrine organs may produce several different hormones.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="67,0,939,998" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_a460de3bdd8d63a6.webp" caption="The endocrine system">
        <description>A labelled anatomical diagram of the human body illustrating the locations of major endocrine glands. The figure uses circular insets to highlight specific organs, including the hypothalamus/pituitary gland, pineal gland, thyroid gland, thymus, pancreas, adrenal gland, testicle, and ovaries.</description>
      </img>
      <img order="1" bbox="72,0,692,998" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_50f99c4302283276.webp" caption="The endocrine system">
        <description>An anatomical diagram titled &quot;The endocrine system&quot; showing a central human figure with circular insets illustrating specific glands. The labelled components are: Hypothalamus, Pituitary gland, Pineal gland, Thyroid gland, Thymus, Pancreas, Adrenal gland, Testicle, and Ovaries.</description>
      </img>
    </images>
  </page>
  <page number="4">
    <text>&lt;h2&gt;HORMONES&lt;/h2&gt;

**Hypothalamus**
TRH, CRH, GHRH
Dopamine
Somatostatin
Vasopressin

**Pineal gland**
Melatonin

**Thyroid and Parathyroid**
T3, T4, Calcitonin
PTH

**Pituitary gland**
GH, TSH, ACTH
FSH, MSH, LH
Prolactin, Oxytocin
Vasopressin

**Liver**
IGF, THPO

**Thymus**
Thymopoietin

**Adrenal**
Androgens
Glucocorticoids
Adrenaline
Noradrenaline

**Stomach**
Gastrin, Ghrelin
Histamine
Somatostatin
Neuropeptide Y

**Kidney**
Calcitriol, Renin
Erythropoietin

**Pancreas**
Insulin, Glucagon
Somatostatin

**Testes**
Androgens
Estradiol, Inhibin

**Ovary, Placenta**
Estrogens
Progesterone

**Uterus**
Prolactin, Relaxin

![](L6 Endocrine notes_figures/img_14935594d1e3a2b8.webp)</text>
    <formatted_text>#### Hormones by Gland

- **Hypothalamus:** TRH, CRH, GHRH, Dopamine, Somatostatin, Vasopressin
- **Pineal gland:** Melatonin
- **Thyroid and Parathyroid:** T3, T4, Calcitonin, PTH
- **Pituitary gland:** GH, TSH, ACTH, FSH, MSH, LH, Prolactin, Oxytocin, Vasopressin
- **Liver:** IGF, THPO
- **Thymus:** Thymopoietin
- **Adrenal:** Androgens, Glucocorticoids, Adrenaline, Noradrenaline
- **Stomach:** Gastrin, Ghrelin, Histamine, Somatostatin, Neuropeptide Y
- **Kidney:** Calcitriol, Renin, Erythropoietin
- **Pancreas:** Insulin, Glucagon, Somatostatin
- **Testes:** Androgens, Estradiol, Inhibin
- **Ovary, Placenta:** Estrogens, Progesterone
- **Uterus:** Prolactin, Relaxin</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:25:36" confidence="7" anchor="- **Adrenal:** Androgens, Glucocorticoids, Adrenaline, Noradrenaline">
- The adrenal cortex produces ==cortisol, aldosterone, and various androgens==.</insert>
      <insert timestamp="00:03:12" confidence="2" anchor="- **Pancreas:** Insulin, Glucagon, Somatostatin">
- Insulin ==regulates blood glucose==.</insert>
      <insert timestamp="00:04:49" confidence="6" anchor="##### **Type 2 Diabetes**

- Combination of:
  - Insulin resistance.
  - Progres">

&gt; [!note] Lecturer — Type 2 Mechanisms
&gt; Insulin receptors may be affected in Type 2 diabetes.
&gt;
&gt; - The continuing requirement to produce large amounts of insulin can cause beta-cell changes and dysfunction.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="43,158,728,966" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_14935594d1e3a2b8.webp">
        <description>A labelled anatomical diagram of the human endocrine system, showing a male torso with specific glands highlighted and connected to text lists identifying them and their secreted hormones. Visible labels include Hypothalamus (TRH, CRH, GHRH, Dopamine, Somatostatin, Vasopressin), Thyroid and Parathyroid (T3, T4, Calcitonin, PTH), Liver (IGF, THPO), Adrenal (Androgens, Glucocorticoids, Adrenaline, Noradrenaline), Kidney (Calcitriol, Renin, Erythropoietin), and Testes (Androgens, Estradiol, Inhibin).</description>
      </img>
    </images>
  </page>
  <page number="5">
    <text>IMPT!

# Diabetes Mellitus

**Definition**

**Diabetes mellitus (DM)** is a chronic metabolic disorder characterized by persistent **hyperglycaemia (elevated blood glucose levels)** resulting from defects in insulin secretion, insulin action, or both. Prolonged hyperglycaemia can lead to damage of the eyes, kidneys, nerves, cardiovascular system, and oral tissues.

## Aetiology

### Type 1 Diabetes
*   Autoimmune destruction of pancreatic $\beta$-cells.
*   Genetic predisposition (e.g., HLA-associated susceptibility).
*   Environmental triggers such as viral infections may contribute.
*   Results in little or no endogenous insulin production.

### Type 2 Diabetes
*   Combination of:
    *   Insulin resistance.
    *   Progressive $\beta$-cell dysfunction.
*   Risk factors include:
    *   GENETICS: Family history, ethnicity, .
    *   LIFESTYLE: Physical inactivity. Unhealthy diet, Obesity
    *   AGE
    *   OTHERS: Previous gestational diabetes. Polycystic ovary syndrome.

### Gestational Diabetes
*   Pregnancy-induced insulin resistance exceeding pancreatic compensatory capacity.
*   Usually resolves postpartum but increases future risk of Type 2 diabetes.

**DIABETES MELLITUS**

**Healthy**
Glucose
Insulin receptor
Insulin

**Type 1**
Glucose
Pancreas failure to produce insulin

**Type 2**
Glucose
Insulin receptor
Insulin
Cells fail to respond to insulin properly

![DIABETES MELLITUS Healthy Glucose Insulin receptor Insulin Type 1 Glucose Pancreas failure to produce insulin Type 2 Glucose Insulin receptor Insulin Cells fail to respond to insulin properly](L6 Endocrine notes_figures/img_28f26e6a506e6a74.webp)</text>
    <formatted_text>IMPT!

#### Diagram: Diabetes Mellitus

- **Healthy** — Glucose, insulin receptor, insulin
- **Type 1** — Glucose; pancreas failure to produce insulin
- **Type 2** — Glucose, insulin receptor, insulin; cells fail to respond to insulin properly

#### Definition

**Diabetes mellitus (DM)** is a chronic metabolic disorder characterized by persistent **hyperglycaemia (elevated blood glucose levels)** resulting from defects in insulin secretion, insulin action, or both. Prolonged hyperglycaemia can lead to damage of the eyes, kidneys, nerves, cardiovascular system, and oral tissues.

#### Aetiology

##### Type 1 Diabetes

- Autoimmune destruction of pancreatic β-cells.
- Genetic predisposition (e.g., HLA-associated susceptibility).
- Environmental triggers such as viral infections may contribute.
- Results in little or no endogenous insulin production.

##### Type 2 Diabetes

- Combination of:
  - Insulin resistance.
  - Progressive β-cell dysfunction.
- Risk factors include:
  - **Genetics:** family history, ethnicity.
  - **Lifestyle:** physical inactivity, unhealthy diet, obesity.
  - **Age**
  - **Others:** previous gestational diabetes, polycystic ovary syndrome.

##### Gestational Diabetes

- Pregnancy-induced insulin resistance exceeding pancreatic compensatory capacity.
- Usually resolves postpartum but increases future risk of Type 2 diabetes.</formatted_text>
    <images>
      <img order="0" bbox="663,495,981,860" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_28f26e6a506e6a74.webp" caption="DIABETES MELLITUS Healthy Glucose Insulin receptor Insulin Type 1 Glucose Pancreas failure to produce insulin Type 2 Glucose Insulin receptor Insulin Cells fail to respond to insulin properly">
        <description>A schematic diagram comparing the mechanisms of Healthy, Type 1, and Type 2 diabetes mellitus using illustrations of the pancreas, insulin flow, and cellular receptors. It depicts how a healthy pancreas produces insulin to facilitate glucose uptake, whereas Type 1 shows a failure of the pancreas to produce insulin (marked with a red X), and Type 2 illustrates insulin resistance where cells fail to respond to insulin properly despite its presence.</description>
      </img>
    </images>
  </page>
  <page number="6">
    <text>**Epidemiology of Diabetes Mellitus**

**Worldwide**

*   Diabetes mellitus is one of the fastest-growing chronic diseases globally.
*   According to the **2025 International Diabetes Federation (IDF) Diabetes Atlas**, an estimated **589 million adults (20–79 years)** are living with diabetes worldwide, representing approximately **1 in 9 adults**.
*   Around **90–95% of cases are Type 2 diabetes**, while Type 1 diabetes, gestational diabetes, and other forms account for the remainder.
*   Approximately **252 million people are unaware they have diabetes**, increasing the risk of delayed diagnosis and complications.

**Australia**

*   Diabetes is a major public health issue in Australia and is among the leading causes of chronic disease and healthcare burden.
*   The **Australian Institute of Health and Welfare (AIHW)** estimates that in **2022–2024**, around **1 in 15 Australians (approximately 1.3 million people, or 6.5%)** were living with diabetes based on national survey data.
*   Data from the **International Diabetes Federation** estimate that in **2024**, approximately **1.69 million Australian adults aged 20–79 years had diabetes**, corresponding to a prevalence of **7.4%** in that age group.
*   **Type 2 diabetes accounts for the vast majority of cases (around 90%).**
*   The prevalence increases markedly with age, with Australians aged **75 years and older** having the highest rates of disease.
*   Diabetes disproportionately affects:
    *   Aboriginal and Torres Strait Islander peoples
    *   People living in rural and remote areas
    *   Individuals from lower socioeconomic backgrounds
    *   People with obesity and other metabolic risk factors</text>
    <formatted_text>#### Worldwide

- Diabetes mellitus is one of the fastest-growing chronic diseases globally.
- According to the **2025 International Diabetes Federation (IDF) Diabetes Atlas**, an estimated **589 million adults (20–79 years)** are living with diabetes worldwide, representing approximately **1 in 9 adults**.
- Around **90–95% of cases are Type 2 diabetes**, while Type 1 diabetes, gestational diabetes, and other forms account for the remainder.
- Approximately **252 million people are unaware they have diabetes**, increasing the risk of delayed diagnosis and complications.

#### Australia

- Diabetes is a major public health issue in Australia and is among the leading causes of chronic disease and healthcare burden.
- The **Australian Institute of Health and Welfare (AIHW)** estimates that in **2022–2024**, around **1 in 15 Australians (approximately 1.3 million people, or 6.5%)** were living with diabetes based on national survey data.
- Data from the **International Diabetes Federation** estimate that in **2024**, approximately **1.69 million Australian adults aged 20–79 years had diabetes**, corresponding to a prevalence of **7.4%** in that age group.
- **Type 2 diabetes accounts for the vast majority of cases (around 90%).**
- The prevalence increases markedly with age, with Australians aged **75 years and older** having the highest rates of disease.
- Diabetes disproportionately affects:
  - Aboriginal and Torres Strait Islander peoples
  - People living in rural and remote areas
  - Individuals from lower socioeconomic backgrounds
  - People with obesity and other metabolic risk factors</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:06:50" confidence="4" anchor="Approximately **252 million people are unaware they have diabetes**, increasing ">

&gt; [!note] Lecturer — Undiagnosed Diabetes
&gt; Patients may present with periodontal problems before being diagnosed with diabetes.
</insert>
      <insert timestamp="00:06:58" confidence="5" anchor="Diabetes is a major public health issue in Australia and is among the leading ca">

&gt; [!note] Lecturer — Healthcare Burden
&gt; The healthcare burden of diabetes includes effects on working hours, funding, and financing.
</insert>
    </audio_inserts>
  </page>
  <page number="7">
    <text>**General Manifestations**

**Classic symptoms**
*   Polyuria (frequent urination)
*   Polydipsia (excessive thirst)
*   Polyphagia (increased appetite)
*   Fatigue
*   Unexplained weight loss (particularly in Type 1 diabetes)
*   Blurred vision

**Chronic complications**

**Microvascular**
*   Diabetic retinopathy
*   Diabetic nephropathy
*   Peripheral neuropathy

**Macrovascular**
*   Coronary artery disease
*   Cerebrovascular disease
*   Peripheral arterial disease

**Other features**
*   Delayed wound healing, susceptibility to infection
*   Affects calcium metabolism - osteopenia
*   Poor circulation
*   Erectile dysfunction

![7 COMMON SYMPTOMS OF TYPE 2 DIABETES](L6 Endocrine notes_figures/img_70aff7edc31c0838.webp)
![Major Complications of Diabetes](L6 Endocrine notes_figures/img_154ffa9b3eebd2a8.webp)</text>
    <formatted_text>#### Classic Symptoms

- Polyuria (frequent urination)
- Polydipsia (excessive thirst)
- Polyphagia (increased appetite)
- Fatigue
- Unexplained weight loss (particularly in Type 1 diabetes)
- Blurred vision

#### Chronic Complications

##### Microvascular

- Diabetic retinopathy
- Diabetic nephropathy
- Peripheral neuropathy

##### Macrovascular

- Coronary artery disease
- Cerebrovascular disease
- Peripheral arterial disease

#### Other Features

- Delayed wound healing, susceptibility to infection
- Affects calcium metabolism — osteopenia
- Poor circulation
- Erectile dysfunction</formatted_text>
    <images>
      <img order="0" bbox="592,144,926,525" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="figure" path="L6 Endocrine notes_figures/img_70aff7edc31c0838.webp" caption="7 COMMON SYMPTOMS OF TYPE 2 DIABETES">
        <description>This labelled illustration depicts an overweight male figure surrounded by circular icons representing seven common symptoms of Type 2 diabetes. Lines connect the icons to specific body parts or general areas, identifying conditions such as blurred vision, fungal infection/itching, unexplained weight loss, numbness of hands and feet, frequent urination, constant hunger, and slow healing of wounds.</description>
      </img>
      <img order="1" bbox="645,625,829,895" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_154ffa9b3eebd2a8.webp" caption="Major Complications of Diabetes">
        <description>An anatomical diagram of the human body showing the circulatory system, with beams connecting specific organs and tissues to magnified views illustrating complications of diabetes. The surrounding details include a cross-section of an eye (retinopathy), a brain (cerebrovascular disease), a heart (coronary artery disease), a kidney (nephropathy), a neuron (neuropathy), and a foot with visible veins (peripheral arterial disease).</description>
      </img>
    </images>
  </page>
  <page number="8">
    <text># General Management

Management aims to maintain glycaemic control and prevent complications through a multidisciplinary approach.

## Lifestyle interventions
*   Healthy diet
*   Regular physical activity
*   Smoking and alcohol control

## Medications (depending on type and severity)
*   Insulin therapy (long and short)
*   Oral hypoglycaemic agents: Sulfonylureas (glipizide, tolazamide), DDP-4 inhibits (sitagliptin), Biguanides (metformin), Alpha-glucosidase inhibitors (acarbose, miglitol) SGLT2 inhibitors
*   Injectable non-insulin therapies

## Surgery
*   Amputation of gangrenous areas

## Monitoring
*   Self-monitoring of blood glucose and Regular HbA1c assessment.
*   Blood pressure and lipid management.
*   OTHER DISEASE: Screening for kidney disease, retinopathy, neuropathy, and cardiovascular disease.

Increased prevalence in use of empagliflozin (and other SGLT2 inhibitors)
- Decrease oxidative stress but reducing load to proxiaml tubutles in kidneys, protecting kidney functions
- Mainly increase excretion of glucose through urine

Risk of Euglycaemic ketoacidosis, particularly after GA

&lt;table&gt;
  &lt;tr&gt;
    &lt;th&gt;&lt;/th&gt;
    &lt;th&gt;Blood glucose&lt;/th&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Glucose alert value&lt;/td&gt;
    &amp;lt;70 mg/dL&lt;br&gt;(3.9 mmol/L)&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Clinically significant hypoglycemia&lt;/td&gt;
    &amp;lt;54 mg/dL&lt;br&gt;(3.0 mmol/L)&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Severe hypoglycemia&lt;/td&gt;
    No specific glucose level&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;Relative hypoglycemia&lt;/td&gt;
    No specific glucose level&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

![](L6 Endocrine notes_figures/img_0b6fe6b688e8cebb.webp)
![](L6 Endocrine notes_figures/img_59d2da6ebf449101.webp)
![](L6 Endocrine notes_figures/img_32bf153c2904231c.webp)</text>
    <formatted_text>Management aims to maintain glycaemic control and prevent complications through a multidisciplinary approach.

#### Lifestyle Interventions

- Healthy diet
- Regular physical activity
- Smoking and alcohol control

#### Medications (depending on type and severity)

- Insulin therapy (long and short)
- Oral hypoglycaemic agents: sulfonylureas (glipizide, tolazamide), DDP-4 inhibitors (sitagliptin), biguanides (metformin), alpha-glucosidase inhibitors (acarbose, miglitol), SGLT2 inhibitors
- Injectable non-insulin therapies

#### Surgery

- Amputation of gangrenous areas

#### Monitoring

- Self-monitoring of blood glucose and regular HbA1c assessment.
- Blood pressure and lipid management.
- Other disease: screening for kidney disease, retinopathy, neuropathy, and cardiovascular disease.

#### SGLT2 Inhibitors

Increased prevalence in use of empagliflozin (and other SGLT2 inhibitors):

- Decrease oxidative stress by reducing load to proximal tubules in kidneys, protecting kidney function
- Mainly increase excretion of glucose through urine

Risk of euglycaemic ketoacidosis, particularly after GA.

#### Hypoglycaemia Thresholds

| | Blood glucose |
| :--- | :--- |
| Glucose alert value | &lt;70 mg/dL (3.9 mmol/L) |
| Clinically significant hypoglycemia | &lt;54 mg/dL (3.0 mmol/L) |
| Severe hypoglycemia | No specific glucose level |
| Relative hypoglycemia | No specific glucose level |</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:11:26" confidence="7" anchor="Oral hypoglycaemic agents: sulfonylureas (glipizide, tolazamide), DDP-4 inhibito">

&gt; [!note] Lecturer — Insulin Therapy
&gt; Metformin has commonly been used as an initial prescription, with treatment potentially progressing to sulfonylureas, other medications, and injectable insulin.
&gt;
&gt; - Insulin is a mainstay treatment for Type 1 diabetes.
&gt; - Long-term injected insulin may produce autoimmune responses because the body recognises injected insulin as foreign, potentially reducing the effects of therapy.
</insert>
      <insert timestamp="00:12:56" confidence="5" anchor="Risk of euglycaemic ketoacidosis, particularly after GA.">

&gt; [!note] Lecturer — SGLT2 Anaesthesia Risk
&gt; Patients taking SGLT2 inhibitors should be warned about euglycaemic ketoacidosis.
&gt;
&gt; - The anaesthetist should perform a detailed risk assessment, particularly before general anaesthesia.
</insert>
      <insert timestamp="00:17:27" confidence="6" anchor="#### **Hypoglycaemia Thresholds**

| | Blood glucose |
| :--- | :--- |
| Glucose">

&gt; [!note] Lecturer — Dental Hypoglycaemia Thresholds
&gt; A blood glucose level of approximately 5 mmol/L was described as a useful level for dental practice.
&gt;
&gt; - If a patient is below or approaching this level, they may be given something sweet to drink or suck.
&gt; - A level of 4.0 mmol/L is usually an indicator of hypoglycaemia.
&gt; - Practices may differ, and not all dental practices are equipped or trained to measure blood glucose.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="666,202,956,402" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="photo" path="L6 Endocrine notes_figures/img_0b6fe6b688e8cebb.webp">
        <description>A close-up photograph shows a person using a blue handheld blood glucose meter. The device's screen clearly displays the text 'LOW BLOOD SUGAR', and a test strip is inserted into the top where a drop of blood from a finger prick is being applied.</description>
      </img>
      <img order="1" bbox="674,436,948,860" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_59d2da6ebf449101.webp">
        <description>A table defining blood glucose thresholds for various hypoglycemic states. It lists 'Glucose alert value' as &lt;70 mg/dL (3.9 mmol/L) and 'Clinically significant hypoglycemia' as &lt;54 mg/dL (3.0 mmol/L), while noting that 'Severe hypoglycemia' and 'Relative hypoglycemia' have no specific glucose level.</description>
      </img>
      <img order="2" bbox="674,438,941,889" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_32bf153c2904231c.webp">
        <description>A table defining hypoglycemia categories and their corresponding blood glucose thresholds. It lists Glucose alert value (&lt;70 mg/dL), Clinically significant hypoglycemia (&lt;54 mg/dL), Severe hypoglycemia (no specific level), and Relative hypoglycemia (no specific level).</description>
      </img>
    </images>
  </page>
  <page number="9">
    <text>Diabetes Mellitus

**IMPT!**

| **Access** | • Amputee - wheelchair user, fall risks&lt;br&gt;• Morning appointments (without missing breakfast) - higher endogenous cortisol leading to decreased risk of hypoglycaemia |
| :--- | :--- |
| **Communication** | • Visual disturbances (cataract, diabetic retinopathy)&lt;br&gt;• Patients might not be aware they have diabetes mellitus |
| **Consent** | • Usually no significant neurological impact. |
| **Education** | • Effective periodontal treatment can contribute to modest improvements in glycaemic control.&lt;br&gt;• Fatigue might affect attendance and routine oral hygiene&lt;br&gt;• Inform risk of failure of surgical implants, or poorer healing |
| **Surgery (pre)** | • check BG if needed prior to dental treatment (at least 5.0mmol/L)&lt;br&gt;• Check that food and medications were taken&lt;br&gt;• For GA fasting - place on glucose sliding scale&lt;br&gt;• Appointment - short morning better |
| **(peri)** | • Watch for HypoG signs (sweat, confusion, tremors)&lt;br&gt;• Suture, antibiotics, may help with managing post op infection |
| **(post)** | • Higher risk of oral infection/dry socket&lt;br&gt;• Risk of denture stomatitis is higher&lt;br&gt;• most NSAIDS, metronidazole and azithromycin may boost oral hypoglycaemic agents,&lt;br&gt;• ciprofloxacin can compete with insulin. |
| **Spread** | Diabetes Mellitus is not contagious |
| **Oral manifestation** | • Increased prevalence and severity of periodontal disease.&lt;br&gt;• Xerostomia (dry mouth). Burning mouth symptoms.&lt;br&gt;• Delayed wound healing following dental procedures. Increased susceptibility to oral infections. Oral candidiasis.&lt;br&gt;• Increased dental caries risk secondary to xerostomia.&lt;br&gt;• Altered taste sensation Halitosis.&lt;br&gt;• Enlarged parotid glands (occasionally). |
| **Related conditions** | • High BG increases risk of osteoporosis (MRONJ), Cardiovascular, Cerebrovasculr issues,&lt;br&gt;• Those with late stage diabetes may have chronic renal failure, amputations, visual disturbances etc&lt;br&gt;• Obesity |

![](L6 Endocrine notes_figures/img_c5b4998512ad5772.webp)</text>
    <formatted_text>IMPT!

#### Access

- Amputee — wheelchair user, fall risks
- Morning appointments (without missing breakfast) — higher endogenous cortisol leading to decreased risk of hypoglycaemia

#### Communication

- Visual disturbances (cataract, diabetic retinopathy)
- Patients might not be aware they have diabetes mellitus

#### Consent

- Usually no significant neurological impact.

#### Education

- Effective periodontal treatment can contribute to modest improvements in glycaemic control.
- Fatigue might affect attendance and routine oral hygiene
- Inform risk of failure of surgical implants, or poorer healing

#### Surgery (Pre)

- Check BG if needed prior to dental treatment (at least 5.0 mmol/L)
- Check that food and medications were taken
- For GA fasting — place on glucose sliding scale
- Appointment — short morning better

#### Surgery (Peri)

- Watch for hypoG signs (sweat, confusion, tremors)
- Suture, antibiotics, may help with managing post-op infection

#### Surgery (Post)

- Higher risk of oral infection/dry socket
- Risk of denture stomatitis is higher
- Most NSAIDS, metronidazole and azithromycin may boost oral hypoglycaemic agents
- Ciprofloxacin can compete with insulin

#### Spread

Diabetes Mellitus is not contagious.

#### Oral Manifestations

- Increased prevalence and severity of periodontal disease.
- Xerostomia (dry mouth). Burning mouth symptoms.
- Delayed wound healing following dental procedures. Increased susceptibility to oral infections. Oral candidiasis.
- Increased dental caries risk secondary to xerostomia.
- Altered taste sensation. Halitosis.
- Enlarged parotid glands (occasionally).

#### Related Conditions

- High BG increases risk of osteoporosis (MRONJ), cardiovascular, cerebrovascular issues
- Those with late stage diabetes may have chronic renal failure, amputations, visual disturbances etc
- Obesity</formatted_text>
    <audio_inserts count="5">
      <insert timestamp="00:14:30" confidence="3" anchor="Amputee — wheelchair user, fall risks
- Morning appointments (without missing br">

&gt; [!note] Lecturer — Dental Access
&gt; Access to smaller dental operatories may be difficult for patients using wheelchairs or crutches.
&gt;
&gt; - Visual disturbances associated with cataracts or retinopathy may also affect access and navigation.
</insert>
      <insert timestamp="00:16:04" confidence="5" anchor="Fatigue might affect attendance and routine oral hygiene
- Inform risk of failur">

&gt; [!note] Lecturer — Periodontal Health
&gt; Diabetes and periodontal health have a bidirectional relationship.
&gt;
&gt; - Improved blood glucose control improves periodontal health.
&gt; - Periodontal treatment and improved periodontal health can improve glycaemic control, a relationship confirmed through clinical trials.
</insert>
      <insert timestamp="00:14:45" confidence="5" anchor="Check that food and medications were taken
- For GA fasting — place on glucose s">

&gt; [!note] Lecturer — Preoperative Food Intake
&gt; Patients should eat some food before the appointment, such as a slice of sandwich or an equivalent amount.
&gt;
&gt; - Patients at high risk of hypoglycaemia should be advised to eat more before treatment, particularly if they are anxious.
</insert>
      <insert timestamp="00:19:14" confidence="3" anchor="Most NSAIDS, metronidazole and azithromycin may boost oral hypoglycaemic agents
">

&gt; [!note] Lecturer — Postoperative Medication
&gt; Paracetamol was described as the preferred first-line painkiller, and amoxicillin as a generally reliable antibiotic choice.
&gt;
&gt; - NSAIDs, metronidazole, and azithromycin are not necessarily prohibited, but their risks and benefits must be balanced.
</insert>
      <insert timestamp="00:19:59" confidence="5" anchor="Dry mouth). Burning mouth symptoms.
- Delayed wound healing following dental pro">

&gt; [!note] Lecturer — Xerostomia Causes
&gt; Dry mouth may be related to medication or high blood glucose.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="93,26,975,1000" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_c5b4998512ad5772.webp">
        <description>A structured table with a two-column layout featuring color-coded category headers on the left (Access, Communication, Consent, Education, Surgery, Spread, Oral manifestation, Related conditions) and corresponding bulleted clinical notes on the right regarding diabetes management.</description>
      </img>
    </images>
  </page>
  <page number="10">
    <text>1. Definition &lt;b&gt;IMPT!&lt;/b&gt;

&lt;b&gt;Adrenal insufficiency (AI)&lt;/b&gt; is an endocrine disorder in which the adrenal glands fail to produce sufficient &lt;b&gt;glucocorticoids (primarily cortisol)&lt;/b&gt;, and in some cases &lt;b&gt;mineralocorticoids (aldosterone)&lt;/b&gt; and adrenal androgens. Inadequate cortisol production impairs the body's ability to respond to physiological stress, including illness and surgery.

The main types are:

• Primary adrenal insufficiency – due to destruction or dysfunction of the adrenal cortex.
• Secondary adrenal insufficiency – caused by reduced secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland.
• Tertiary adrenal insufficiency – often results from suppression of the hypothalamic–pituitary–adrenal axis following prolonged corticosteroid therapy.

2. Aetiology

&lt;b&gt;Primary Adrenal Insufficiency&lt;/b&gt;

• &lt;b&gt;&lt;u&gt;Autoimmune adrenal destruction (most common in developed countries)&lt;/u&gt;&lt;/b&gt;
• Infections (e.g., tuberculosis, fungal infections)
• Adrenal haemorrhage or infarction
• Metastatic cancer
• Genetic disorders
• Bilateral adrenalectomy

&lt;b&gt;Secondary Adrenal Insufficiency&lt;/b&gt;

• Pituitary tumours or surgery
• Pituitary irradiation
• Pituitary infarction
• ACTH deficiency

&lt;b&gt;Tertiary Adrenal Insufficiency&lt;/b&gt;

• Long-term systemic corticosteroid therapy with abrupt withdrawal
• Hypothalamic disease
• &lt;b&gt;&lt;u&gt;Chronic suppression of the hypothalamic–pituitary–adrenal axis&lt;/u&gt;&lt;/b&gt;</text>
    <formatted_text>**Adrenal insufficiency (AI)** is an endocrine disorder in which the adrenal glands fail to produce sufficient **glucocorticoids (primarily cortisol)**, and in some cases **mineralocorticoids (aldosterone)** and adrenal androgens. Inadequate cortisol production impairs the body's ability to respond to physiological stress, including illness and surgery.

#### Main Types

- **Primary adrenal insufficiency** – due to destruction or dysfunction of the adrenal cortex.
- **Secondary adrenal insufficiency** – caused by reduced secretion of adrenocorticotropic hormone (ACTH) from the pituitary gland.
- **Tertiary adrenal insufficiency** – often results from suppression of the hypothalamic–pituitary–adrenal axis following prolonged corticosteroid therapy.

#### Aetiology

**Primary Adrenal Insufficiency**

- **Autoimmune adrenal destruction (most common in developed countries)**
- Infections (e.g., tuberculosis, fungal infections)
- Adrenal haemorrhage or infarction
- Metastatic cancer
- Genetic disorders
- Bilateral adrenalectomy

**Secondary Adrenal Insufficiency**

- Pituitary tumours or surgery
- Pituitary irradiation
- Pituitary infarction
- ACTH deficiency

**Tertiary Adrenal Insufficiency**

- Long-term systemic corticosteroid therapy with abrupt withdrawal
- Hypothalamic disease
- **Chronic suppression of the hypothalamic–pituitary–adrenal axis**</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:21:58" confidence="2" anchor="**Adrenal insufficiency (AI)** is an endocrine disorder in which the adrenal gla">
- ==Aldosterone deficiency can also adversely affect blood pressure.==</insert>
      <insert timestamp="00:36:11" confidence="5" anchor="- **Tertiary adrenal insufficiency** – often results from suppression of the hyp">

&gt; [!note] Lecturer — Tertiary Insufficiency
&gt; Tertiary adrenal insufficiency may become apparent when long-term corticosteroid treatment is withdrawn.
</insert>
      <insert timestamp="00:23:44" confidence="5" anchor="- **ACTH deficiency**">
- ==Infection and stroke may also contribute to secondary adrenal insufficiency.==
- ==ACTH normally signals the adrenal glands to secrete cortisol.==</insert>
    </audio_inserts>
  </page>
  <page number="11">
    <text>STRESS
REGULATION
CYCLE

Stress and Diurnal
regulation (controlled by
light-dark day pattern)
affects endogenous steroid
release

Corticotropin-Releasing Hormone
(CRH)
Adrenocorticotropic Hormone
(ACTH)

**Adrenal Medulla**
**(stimulated by SNS)**
• adrenaline ~85% of
secretion, rapid ‘fight-
flight’ response
• noradrenaline ~15% of
secretion, mainly
vasoconstrict to maintain
BP

revision, not tested

![](L6 Endocrine notes_figures/img_29951bbe4e6ed45c.webp)</text>
    <formatted_text>*Revision, not tested*

- Stress and diurnal regulation (controlled by the light–dark day pattern) affects endogenous steroid release.
- Corticotropin-Releasing Hormone (CRH) and Adrenocorticotropic Hormone (ACTH) are involved in the regulatory pathway.
- **Adrenal Medulla** (stimulated by the SNS):
  - Adrenaline ~85% of secretion, rapid 'fight-flight' response
  - Noradrenaline ~15% of secretion, mainly vasoconstricts to maintain BP</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:25:48" confidence="8" anchor="- Noradrenaline ~15% of secretion, mainly vasoconstricts to maintain BP">

&gt; [!note] Lecturer — Stress Pathway
&gt; The stress response has sympathetic and endocrine components. In the endocrine pathway, the hypothalamus releases corticotropin-releasing hormone, which stimulates pituitary ACTH release; ACTH then acts on the adrenal cortex to produce cortisol, aldosterone and androgens.
&gt;
&gt; - The cycle includes negative feedback and regulation.
&gt; - Cortisol secretion increases in the early morning and helps a person wake up.
&gt; - The adrenal medulla produces epinephrine and norepinephrine, which are catecholamines.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="299,2,990,1000" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_29951bbe4e6ed45c.webp">
        <description>This labelled flowchart illustrates the regulation of adrenal hormone release, depicting the hypothalamic-pituitary-adrenal axis and sympathetic nervous system inputs. It details the anatomical zones of the adrenal cortex (glomerular, fascicular, and reticular) and medulla, mapping specific stimuli like stress, Angiotensin II, and Hyperkalemia to the production of hormones such as aldosterone, cortisol, and epinephrine.</description>
      </img>
    </images>
  </page>
  <page number="12">
    <text>**3. Epidemiology**

**Global**

• Primary adrenal insufficiency is **rare**, affecting approximately **100–140 people per million population** in developed countries.

• Autoimmune disease accounts for most cases in high-income countries, while infectious causes remain important in some low- and middle-income regions.

• Secondary/tertiary adrenal insufficiency is generally more common than primary adrenal insufficiency due to pituitary disease and widespread corticosteroid use.

**Australia**

• Adrenal insufficiency is an uncommon condition

• Addison’s disease (Autoimmune adrenalitis) is the leading cause of primary adrenal insufficiency in Australia.

**4. General Manifestations**

**Common symptoms [stress symptoms]**

• Chronic fatigue

• Muscle weakness

• Weight loss

• Loss of appetite

• Nausea and vomiting

• Abdominal pain

• Dizziness or postural hypotension

**Features of Primary Adrenal Insufficiency**

• Hyperpigmentation of the skin and mucous membranes

• Salt craving

• Hypotension Hyponatraemia Hyperkalaemia

• Dehydration

**Adrenal Crisis (Medical Emergency)**</text>
    <formatted_text>#### Global

- Primary adrenal insufficiency is **rare**, affecting approximately **100–140 people per million population** in developed countries.
- Autoimmune disease accounts for most cases in high-income countries, while infectious causes remain important in some low- and middle-income regions.
- Secondary/tertiary adrenal insufficiency is generally more common than primary adrenal insufficiency due to pituitary disease and widespread corticosteroid use.

#### Australia

- Adrenal insufficiency is an uncommon condition.
- Addison's disease (autoimmune adrenalitis) is the leading cause of primary adrenal insufficiency in Australia.

#### General Manifestations

**Common symptoms [stress symptoms]**

- Chronic fatigue
- Muscle weakness
- Weight loss
- Loss of appetite
- Nausea and vomiting
- Abdominal pain
- Dizziness or postural hypotension

**Features of Primary Adrenal Insufficiency**

- Hyperpigmentation of the skin and mucous membranes
- Salt craving
- Hypotension, hyponatraemia, hyperkalaemia
- Dehydration

**Adrenal Crisis (Medical Emergency)**</formatted_text>
  </page>
  <page number="13">
    <text>**5. General Management**

**Hormone replacement**

• Lifelong glucocorticoid replacement (e.g., hydrocortisone or prednisolone)

• Mineralocorticoid replacement (e.g., fludrocortisone) for primary adrenal insufficiency

**Stress dosing**

• Patients may require increased (&quot;stress-dose&quot;) glucocorticoids during illness, surgery, or major physiological stress.

**Patient education**

• Carry medical alert identification.

• Maintain an emergency steroid plan.

• Avoid abrupt discontinuation of prescribed corticosteroids.

• Have access to emergency injectable hydrocortisone when indicated.

**Regular follow-up**

• Endocrinology review

• Monitoring of blood pressure, electrolytes, and symptoms

• Adjustment of replacement therapy as needed

•

**IMPT!**

**6. Oral Manifestations**

Patients with adrenal insufficiency may exhibit:

• Diffuse or patchy **oral mucosal hyperpigmentation**, particularly in primary adrenal insufficiency

• Delayed wound healing (especially in patients receiving corticosteroid therapy)

• Increased susceptibility to oral infections if immunosuppressed

• Oral candidiasis in patients using corticosteroids

• Fatigue that may affect tolerance of lengthy dental appointments

• oral pigmentation may involve the buccal mucosa, gingiva, tongue, palate, or lips and may be one of the earliest clinical signs of Addison disease.</text>
    <formatted_text>#### Hormone Replacement

- Lifelong glucocorticoid replacement (e.g., hydrocortisone or prednisolone)
- Mineralocorticoid replacement (e.g., fludrocortisone) for primary adrenal insufficiency

#### Stress Dosing

- Patients may require increased (&quot;stress-dose&quot;) glucocorticoids during illness, surgery, or major physiological stress.

#### Patient Education

- Carry medical alert identification.
- Maintain an emergency steroid plan.
- Avoid abrupt discontinuation of prescribed corticosteroids.
- Have access to emergency injectable hydrocortisone when indicated.

#### Regular Follow-Up

- Endocrinology review
- Monitoring of blood pressure, electrolytes, and symptoms
- Adjustment of replacement therapy as needed

Patients with adrenal insufficiency may exhibit:

- Diffuse or patchy **oral mucosal hyperpigmentation**, particularly in primary adrenal insufficiency
- Delayed wound healing (especially in patients receiving corticosteroid therapy)
- Increased susceptibility to oral infections if immunosuppressed
- Oral candidiasis in patients using corticosteroids
- Fatigue that may affect tolerance of lengthy dental appointments
- Oral pigmentation may involve the buccal mucosa, gingiva, tongue, palate, or lips and may be one of the earliest clinical signs of Addison disease.</formatted_text>
  </page>
  <page number="14">
    <text># IMPT!

| | |
| :--- | :--- |
| **Access** | • Morning appointments - higher endogenous cortisol |
| **Communication** | • Pituitary tumor can compress optic chiasma |
| **Consent** | • Usually no significant neurological impact. |
| **Education** | • Corticosteroid use, infections, and oral health&lt;br&gt;• Low-calorie, low fat, low sodium, protein rich, potassium rich, calcium rich diet for corticosteroid treatment may be helpful for caries risk. |
| **Surgery (pre)** | • Steroid Cover for invasive dentistry - **Gibson &amp; Ferguson 2004**&lt;br&gt;• Steroid Cover (IV) for GA - **Nicholson et al., 1998**&lt;br&gt;• Appointment - short morning better |
| **(peri)** | • Look out for signs of Adrenal Crisis |
| **(post)** | • Higher risk of oral infections&lt;br&gt;• Azole antifunals and some macrolides can increase plasma glucocorticoid levels&lt;br&gt;• NSAIDS and glucocorticoid use may increase risk of Gastrointestinal Injury |
| **Spread** | • Addison’s disease is not contagious |
| **Oral manifestation** | • Oral pigmentation in buccal mucosa, gingiva, tongue, palate, or lip&lt;br&gt;• Other risk of infection due to steroid use&lt;br&gt;• Patient on long-term corticosteroids may be susceptible to infection and reactivation of Herpes virus, Varicella zoster, Hep B/C etc. |
| **Related conditions** | • Increased risk of osteoporosis with long-term steroid use&lt;br&gt;• Cause of steroid prescription: SLE, Rheumatoid Arthritis etc. |

![Adrenal Insufficiencies](L6 Endocrine notes_figures/img_303d14ec85fe6ceb.webp)</text>
    <formatted_text>- **Access** – Morning appointments (higher endogenous cortisol)
- **Communication** – Pituitary tumour can compress optic chiasma
- **Consent** – Usually no significant neurological impact
- **Education** –
  - Corticosteroid use, infections, and oral health
  - Low-calorie, low-fat, low-sodium, protein-rich, potassium-rich, calcium-rich diet for corticosteroid treatment may be helpful for caries risk
- **Surgery (pre)** –
  - Steroid cover for invasive dentistry — *Gibson &amp; Ferguson 2004*
  - Steroid cover (IV) for GA — *Nicholson et al., 1998*
  - Appointment: short morning better
- **Surgery (peri)** – Look out for signs of adrenal crisis
- **Surgery (post)** –
  - Higher risk of oral infections
  - Azole antifungals and some macrolides can increase plasma glucocorticoid levels
  - NSAIDs and glucocorticoid use may increase risk of gastrointestinal injury
- **Spread** – Addison's disease is not contagious
- **Oral manifestation** –
  - Oral pigmentation in buccal mucosa, gingiva, tongue, palate, or lip
  - Other risk of infection due to steroid use
  - Patients on long-term corticosteroids may be susceptible to infection and reactivation of Herpes virus, Varicella zoster, Hep B/C, etc.
- **Related conditions** –
  - Increased risk of osteoporosis with long-term steroid use
  - Cause of steroid prescription: SLE, rheumatoid arthritis, etc.</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:32:04" confidence="3" anchor="- **Access** – Morning appointments (higher endogenous cortisol)
- **Communicati">

&gt; [!note] Lecturer — Appointment Planning
&gt; Patients with Addison’s disease may not produce increased morning cortisol, but morning treatment remains acceptable when they are taking their regular replacement doses. Communication is generally unaffected unless the patient is very fatigued.
</insert>
      <insert timestamp="00:34:36" confidence="7" anchor="- **Surgery (peri)** – Look out for signs of adrenal crisis">

&gt; [!note] Lecturer — Adrenal Decompensation
&gt; During dental treatment, monitor for possible decompensation, including hypovolaemia, confusion and tiredness. Adrenal crisis can occur after dental treatment, although it is generally rare during dental treatment.
</insert>
      <insert timestamp="00:36:24" confidence="8" anchor="- **Related conditions** –
  - Increased risk of osteoporosis with long-term ste">

&gt; [!note] Lecturer — Bisphosphonate Risk
&gt; Patients with Addison’s disease may be taking bisphosphonates. This increases the risk of medication-related osteonecrosis during dental treatment.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="65,28,938,1000" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_303d14ec85fe6ceb.webp" caption="Adrenal Insufficiencies">
        <description>A two-column table with color-coded category headers on the left and corresponding bullet-pointed clinical guidelines on the right. The categories include Access, Communication, Consent, Education, Surgery (pre/peri/post), Spread, Oral manifestation, and Related conditions.</description>
      </img>
    </images>
  </page>
  <page number="15">
    <text>Side effects of steroids

IMPT!

| Organ system | Complication | Considerations |
| :--- | :--- | :--- |
| Cardiovascular/renal | Hypertension&lt;br&gt;Sodium and water retention&lt;br&gt;Peripheral edema | Use with caution in heart failure and renal disease&lt;br&gt;Electrolyte and BP* monitoring |
| Endocrine/metabolic | Cushingoid appearance and weight gain&lt;br&gt;Elevated serum glucose | Monitor for signs of adrenal insufficiency&lt;br&gt;Monitor serum glucose&lt;br&gt;Diet and exercise education |
| Gastrointestinal | Peptic ulcer&lt;br&gt;Abdominal discomfort | H2 blocker of proton pump inhibitors |
| Infectious | Immunosuppression&lt;br&gt;Suprainfection: Fungal, parasitic&lt;br&gt;Reactivation of infection | Monitor for signs of infection&lt;br&gt;Consider stress dosing |
| Integumentary | Impaired wound healing | Monitor for signs and symptoms of infection |
| Musculoskeletal | Myopathy&lt;br&gt;Increased calcium excretion | Falls risk evaluation&lt;br&gt;Oral supplements or possibly bisphosphonates with prolonged use and life expectancy |
| Ophthalmologic | Cataracts&lt;br&gt;Glaucoma | Safety&lt;br&gt;Ophthalmological evaluation |
| Psychiatric | Anxiety&lt;br&gt;Depression&lt;br&gt;Mood disorder | Appropriate screening tools&lt;br&gt;Psychotherapy&lt;br&gt;Pharmacotherapeutics |

*BP: Blood pressure.

Schwarzrock, Camille. (2016). Collaboration in the presence of cerebral edema: The complications o steroids. Surgical Neurology International. 7. 185. 10.4103/2152-7806.179228.

![](L6 Endocrine notes_figures/img_6fa150b2f2267d75.webp)</text>
    <formatted_text>| Organ System | Complication | Considerations |
| :--- | :--- | :--- |
| Cardiovascular/renal | Hypertension; sodium and water retention; peripheral edema | Use with caution in heart failure and renal disease; electrolyte and BP* monitoring |
| Endocrine/metabolic | Cushingoid appearance and weight gain; elevated serum glucose | Monitor for signs of adrenal insufficiency; monitor serum glucose; diet and exercise education |
| Gastrointestinal | Peptic ulcer; abdominal discomfort | H2 blockers or proton pump inhibitors |
| Infectious | Immunosuppression; suprainfection (fungal, parasitic); reactivation of infection | Monitor for signs of infection; consider stress dosing |
| Integumentary | Impaired wound healing | Monitor for signs and symptoms of infection |
| Musculoskeletal | Myopathy; increased calcium excretion | Falls risk evaluation; oral supplements or possibly bisphosphonates with prolonged use and life expectancy |
| Ophthalmologic | Cataracts; glaucoma | Safety; ophthalmological evaluation |
| Psychiatric | Anxiety; depression; mood disorder | Appropriate screening tools; psychotherapy; pharmacotherapeutics |

\*BP: Blood pressure.

*Schwarzrock, Camille. (2016). Collaboration in the presence of cerebral edema: The complications of steroids. Surgical Neurology International, 7, 185. 10.4103/2152-7806.179228.*</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:35:41" confidence="13" anchor="*Schwarzrock, Camille. (2016). Collaboration in the presence of cerebral edema: ">

&gt; [!note] Lecturer — Corticosteroid Effects
&gt; Long-term, particularly high-dose, corticosteroid use may cause a buffalo hump, increased facial hair and an increased risk of diabetes mellitus. Other possible effects include muscle wasting, osteopenia, osteoporosis and personality changes.
&gt;
&gt; - Latent infections such as hepatitis B, tuberculosis, HIV, herpes and varicella zoster may reactivate.
&gt; - Oral manifestations may include vesicles or multiple blisters, including lesions affecting one half of the palate.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="202,22,755,943" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_6fa150b2f2267d75.webp">
        <description>A three-column table titled &quot;Side effects of steroids&quot; that categorizes complications by organ system. The columns are labeled &quot;Organ system,&quot; &quot;Complication,&quot; and &quot;Considerations,&quot; listing specific adverse effects like hypertension, Cushingoid appearance, and peptic ulcers alongside monitoring strategies.</description>
      </img>
    </images>
  </page>
  <page number="16">
    <text># Thyroid gland

• Thyroid gland secretes several thyroid hormones. Main hormone is thyroxine, also called T4. Calcitonin stops breakdown of bones and lowers body calcium level
• Thyroid hormones act throughout the body, influencing metabolism, growth and development, and body temperature.
• Thyroid function does not change greatly with ageing

• Breathing
• Heart rate
• Central Peripheral nervous systems
• Body weight
• Muscle strength
• Menstrual cycles
• Body temperature
• Cholesterol levels

![Thyroid hormones](L6 Endocrine notes_figures/img_f9503071576d2240.webp)</text>
    <formatted_text>#### Thyroid Gland

- The thyroid gland secretes several thyroid hormones. The main hormone is thyroxine, also called T4. Calcitonin stops breakdown of bones and lowers body calcium level.
- Thyroid hormones act throughout the body, influencing metabolism, growth and development, and body temperature.
- Thyroid function does not change greatly with ageing.

#### Thyroid Gland Function

Thyroid hormones influence:

- Breathing
- Heart rate
- Central and peripheral nervous systems
- Body weight
- Muscle strength
- Menstrual cycles
- Body temperature
- Cholesterol levels</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:40:30" confidence="7" anchor="- The thyroid gland secretes several thyroid hormones. The main hormone is thyro">
- ==The thyroid gland is located around the neck and is palpated during the initial assessment.==</insert>
      <insert timestamp="00:42:01" confidence="4" anchor="- Cholesterol levels">
- ==Excess thyroxine can increase heart rate and cause palpitations.==
- ==Thyroid regulation operates through a negative feedback system.==</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="691,725,916,999" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_f9503071576d2240.webp" caption="Thyroid hormones">
        <description>This is a labelled schematic diagram illustrating the hypothalamic-pituitary-thyroid axis. It depicts a sagittal view of the head and neck, with a magnified inset showing the pituitary gland's role in regulating the thyroid via hormonal feedback loops.</description>
      </img>
    </images>
  </page>
  <page number="17">
    <text>**Causes of Hyperthyroidism**

**Autoimmune:** Graves' disease (most common cause)
- TSH receptor antibodies secreted (TRAb and TMAb)

Toxic multinodular goitre

Iatrogenic intake of excess hormones
**TSH secreting pituitary adenoma** (rare) - increased TSH

**Prevalence 0.3% in Australia. affects women 10x more than men**

**Causes of Hypothyroidism**

**Autoimmune:** Hashimoto's thyroiditis (most common non-iodine cause)

**Iodine deficiency** (most common worldwide)

**Iatrogenic:** thyroidectomy, radioactive iodine therapy
**Secondary hypothyroidism:** pituitary disease causing low TSH

Prevalence is 1-2% in countries with sufficient iodine. More common in women, older than 65 years, and ‘white’ individuals

Key differences

**Hyperthyroidism**

Raised pulse, hypertension, tremors, warm skin, weight loss
Anxiety, irritability
Exophthalmus, thyroid swell/lump (goitre), fine brittle hair
Thyrotoxic periodic paralysis - weakness attacks (mild-severe)
**THYROTOXIC CRISIS** - extreme anxiety, bomiting and abdominal pain, tachycardia, stupor, coma

Symptomatic control e.g. beta-blockers
Anti-thyroid drugs (carbimazole, propylthiouracil, methimazole for 18 months)
Radioactive iodine, very effective, although results in long-term hypothyroid
Surgery for large goitres or those where drugs are ineffective

Worldwide, autoimmune disease is the predominant cause where iodine intake is adequate

**Hypothyroidism**

Enlarged gland (goitre) due to overstimulation from TSH
Asymptomatic forms
**MYXEDEMA CRISUS/COMA** (encephalopathy, hypothermia, seizures, hyponatraemia, cariogenic shock, respiratory failure etc)
Cretinism retardation (due to maternal iodine deficiency)

Levothyroxine (synthetic T4), 1.5-1.8 microgram/kg
Reduced in elderly or those with Atrial Fibrillation

Worldwide, **iodine deficiency** remains the leading cause

![Causes of Hyperthyroidism Causes of Hypothyroidism](L6 Endocrine notes_figures/img_a4399b5bde2e5455.webp)
![Hyperthyroidism Key differences Hypothyroidism](L6 Endocrine notes_figures/img_b8acaded387327b8.webp)</text>
    <formatted_text>#### Causes of Hyperthyroidism

- **Autoimmune:** Graves' disease (most common cause) — TSH receptor antibodies secreted (TRAb and TMAb)
- Toxic multinodular goitre
- Iatrogenic intake of excess hormones
- **TSH-secreting pituitary adenoma** (rare) — increased TSH

**Prevalence:** 0.3% in Australia; affects women 10x more than men.

#### Causes of Hypothyroidism

- **Autoimmune:** Hashimoto's thyroiditis (most common non-iodine cause)
- **Iodine deficiency** (most common worldwide)
- **Iatrogenic:** thyroidectomy, radioactive iodine therapy
- **Secondary hypothyroidism:** pituitary disease causing low TSH

**Prevalence:** 1–2% in countries with sufficient iodine. More common in women, older than 65 years, and 'white' individuals.

#### Key Differences

##### Hyperthyroidism

- Raised pulse, hypertension, tremors, warm skin, weight loss
- Anxiety, irritability
- Exophthalmus, thyroid swell/lump (goitre), fine brittle hair
- Thyrotoxic periodic paralysis — weakness attacks (mild–severe)
- **THYROTOXIC CRISIS** — extreme anxiety, vomiting and abdominal pain, tachycardia, stupor, coma

*Treatment:*

- Symptomatic control, e.g. beta-blockers
- Anti-thyroid drugs (carbimazole, propylthiouracil, methimazole for 18 months)
- Radioactive iodine — very effective, although results in long-term hypothyroidism
- Surgery for large goitres or those where drugs are ineffective

&gt; Worldwide, autoimmune disease is the predominant cause where iodine intake is adequate.

##### Hypothyroidism

- Enlarged gland (goitre) due to overstimulation from TSH
- Asymptomatic forms
- **MYXEDEMA CRISIS/COMA** (encephalopathy, hypothermia, seizures, hyponatraemia, cardiogenic shock, respiratory failure, etc.)
- Cretinism retardation (due to maternal iodine deficiency)

*Treatment:*

- Levothyroxine (synthetic T4), 1.5–1.8 microgram/kg
- Reduced in elderly or those with atrial fibrillation

&gt; Worldwide, **iodine deficiency** remains the leading cause.</formatted_text>
    <audio_inserts count="3">
      <insert timestamp="00:45:37" confidence="3" anchor="- **THYROTOXIC CRISIS** — extreme anxiety, vomiting and abdominal pain, tachycar">
- ==Exophthalmos is caused by fat deposition behind the eyes.==</insert>
      <insert timestamp="00:43:24" confidence="6" anchor="- Surgery for large goitres or those where drugs are ineffective">
- ==Treatment of Graves' disease may result in hypothyroidism.==</insert>
      <insert timestamp="00:48:19" confidence="4" anchor="- Reduced in elderly or those with atrial fibrillation">
- ==A reduced amount is generally given to patients with cardiac problems.==</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="58,51,977,431" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_a4399b5bde2e5455.webp" caption="Causes of Hyperthyroidism Causes of Hypothyroidism">
        <description>A two-column comparison table listing the causes and prevalence statistics for hyperthyroidism versus hypothyroidism. The left column details autoimmune causes like Graves' disease, toxic multinodular goitre, and iatrogenic factors, while the right column lists Hashimoto's thyroiditis, iodine deficiency, and secondary causes.</description>
      </img>
      <img order="1" bbox="35,554,962,949" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_b8acaded387327b8.webp" caption="Hyperthyroidism Key differences Hypothyroidism">
        <description>A two-column comparison table contrasting the clinical features, management strategies, and epidemiological causes of Hyperthyroidism (left) and Hypothyroidism (right). The rows detail specific symptoms such as raised pulse versus enlarged gland, treatment options like beta-blockers versus Levothyroxine, and distinct global prevalence factors.</description>
      </img>
    </images>
  </page>
  <page number="18">
    <text>**Hypothyroidism**
effects on the body

feeling cold
goiter
slow heart rate
sore muscles and joints
constipation
menstrual changes

hair loss
fatigue
mood and memory changes
depression
high cholesterol
weight gain
dry skin and hair
brittle nails

MEDICALNEWS TODAY

![Hypothyroidism effects on the body](L6 Endocrine notes_figures/img_5f4c59327b3c3ca8.webp)</text>
    <formatted_text>#### Hypothyroidism: Effects on the Body

- Feeling cold
- Goitre
- Slow heart rate
- Sore muscles and joints
- Constipation
- Menstrual changes
- Hair loss
- Fatigue
- Mood and memory changes
- Depression
- High cholesterol
- Weight gain
- Dry skin and hair
- Brittle nails

*Source: Medical News Today*</formatted_text>
    <images>
      <img order="0" bbox="167,114,847,903" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="diagram" path="L6 Endocrine notes_figures/img_5f4c59327b3c3ca8.webp" caption="Hypothyroidism effects on the body">
        <description>This labelled anatomical diagram illustrates the systemic effects of hypothyroidism on a female body. It maps specific symptoms to affected organs and tissues, including 'hair loss' at the scalp, 'goiter' at the thyroid gland, 'slow heart rate' at the heart, 'sore muscles and joints' in the arm, 'constipation' in the intestines, 'menstrual changes' in the reproductive system, 'weight gain' near the stomach, 'high cholesterol' in the blood vessels, and 'dry skin and hair' and 'brittle nails' on the extremities. A brain region is linked to 'fatigue', 'mood and memory changes', and 'depression', while a snowflake icon represents 'feeling cold'.</description>
      </img>
    </images>
  </page>
  <page number="19">
    <text>&lt;h3&gt;Emergency Management&lt;/h3&gt;
&lt;p&gt;Hypoglycaemia / diabetic crisis&lt;br&gt;
Hyperglycaemia&lt;br&gt;
Adrenal/Addisonian’s Crisis&lt;/p&gt;</text>
    <formatted_text>Endocrine emergencies that may arise in dental practice:

- Hypoglycaemia / diabetic crisis
- Hyperglycaemia
- Adrenal/Addisonian's Crisis</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:46:00" confidence="2" anchor="- Hypoglycaemia / diabetic crisis
- Hyperglycaemia
- Adrenal/Addisonian's Crisis">
- ==Thyrotoxic crisis was mentioned but was not discussed in detail.==</insert>
    </audio_inserts>
  </page>
  <page number="20">
    <text># Hyperglycaemic crisis

**Patient can present with:**
1. confusion, drowsiness, vomiting
2. fruity smelling breadth
3. unconscious (call 911)

**Tests for Diabetic ketoacidosis:**
1. Blood sugar levels over 300mg/dL (16.1mmol/L)
2. near-normal (**euglycemic**) blood sugar level may occur
3. Ketone level and blood pH

For dentistry, less common to see this. If the person is conscious,
*   Do a blood glucose test.
*   Drink plenty of water and
*   Take their prescribed diabetic medications (e.g. Insulin, sulphnoureas )
*   Send to medical clinics to manage **Diabetic Ketoacidosis** (DKA) or **Hyperosmolar hyperglycaemic state** (HHS), which is usually treated through
    1.  Fluid replacement (dilute excess sugar)
    2.  Electrolyte replacement (K and Na replaced to keep muscles, heart and nerves functioning)
    3.  Insulin therapy (reverse ketone buildup and normalise blood sugar)

Managing hyperglycaemic emergencies: General advice (Royal Australia College of General Practitioners)
*   Look for an underlying cause – for example, sepsis, cellulitis, myocardial infarction.
*   If no causes are evident, or if you are unable to urgently assess ketones with the hyperglycaemia and the person is unwell, referral to the nearest emergency department may be prudent.
*   After the event, review medications, dietary intake and hyperglycaemic and sick-day management.
*   Re-evaluate for possible undiagnosed type 1 diabetes.

https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/management-of-type-2-diabetes/managing-glycaemic-emergencies</text>
    <formatted_text>#### Presentation

The patient can present with:

1. Confusion, drowsiness, vomiting
2. Fruity smelling breath
3. Unconscious (call 911)

#### Tests for Diabetic Ketoacidosis

1. Blood sugar levels over 300 mg/dL (16.1 mmol/L)
2. Near-normal (**euglycemic**) blood sugar level may occur
3. Ketone level and blood pH

#### Dental Management

For dentistry, less common to see this. If the person is conscious:

- Do a blood glucose test.
- Drink plenty of water and
- Take their prescribed diabetic medications (e.g. insulin, sulphonylureas)
- Send to medical clinics to manage **Diabetic Ketoacidosis** (DKA) or **Hyperosmolar hyperglycaemic state** (HHS), which is usually treated through:

    1. Fluid replacement (dilute excess sugar)
    2. Electrolyte replacement (K and Na replaced to keep muscles, heart and nerves functioning)
    3. Insulin therapy (reverse ketone buildup and normalise blood sugar)

#### General Advice (Royal Australian College of General Practitioners)

- Look for an underlying cause — for example, sepsis, cellulitis, myocardial infarction.
- If no causes are evident, or if you are unable to urgently assess ketones with the hyperglycaemia and the person is unwell, referral to the nearest emergency department may be prudent.
- After the event, review medications, dietary intake and hyperglycaemic and sick-day management.
- Re-evaluate for possible undiagnosed type 1 diabetes.

https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/management-of-type-2-diabetes/managing-glycaemic-emergencies</formatted_text>
    <audio_inserts count="2">
      <insert timestamp="00:49:53" confidence="6" anchor="1. Confusion, drowsiness, vomiting
2. Fruity smelling breath
3. Unconscious (cal">

&gt; [!note] Lecturer — Hyperglycaemia Causes
&gt; Hyperglycaemia may occur when patients consume too much food or do not take their medications.
&gt;
&gt; - Diagnosis may be difficult and should include asking whether the patient had a heavy meal or forgot to take insulin.
</insert>
      <insert timestamp="00:50:50" confidence="2" anchor="- Take their prescribed diabetic medications (e.g. insulin, sulphonylureas)
- Se">
- ==Stop dental treatment and consider ketone and blood pH testing.==</insert>
    </audio_inserts>
  </page>
  <page number="21">
    <text>Acute adrenal insufficiency
IMPT!
IMPT!
Adrenal/Addisonian’s Crisis

Patient can present with:
1. headache, confusion lethargy, vomiting
2. sudden hypotension / shock, or progress 6-12 hours after dental treatment
3. unconscious

Dx for Adrenal crisis:
1. History (high dose steroid long term / Addisonian )
2. Low BP, 20mmHg lower than usual. (Systolic &lt;100mmHg)

For dentistry, rare. Manage by
• Calling 911/000
• Elevate legs, monitor BP
• Administer hydrocortisone 200mg intramuscularly (or other routes/doses)
• Supportive (hydration, provide oxygen, glucose)

Prevention (from AD Australia):
Minor surgery
e.g. cataract surgery, hernia repairs, laparoscopy with local anaesthetic, endoscopy. Includes dental surgery &gt;1hr and with local anaesthetic.
25mg hydrocortisone IV or 20mg oral with induction/immediately prior to onset procedure

Prevention in dentistry:
• Double dosage of steroid
• Avoid afternoon appointment in severe patients + stressful treatment (crisis can be fatal if occurring when sleeping)
• Avoid dentistry when patient has infection/fever/diarrhoea/sick

Therapeutic Guidelines Pg 151

![Minor surgery e.g. cataract surgery, hernia repairs, laparoscopy with local anaesthetic, endoscopy. Includes dental surgery &gt;1hr and with local anaesthetic. 25mg hydrocortisone IV or 20mg oral with induction/immediately prior to onset procedure](L6 Endocrine notes_figures/img_9ca2c66156982e70.webp)</text>
    <formatted_text>#### Presentation

The patient can present with:

1. Headache, confusion, lethargy, vomiting
2. Sudden hypotension / shock, or progress 6–12 hours after dental treatment
3. Unconscious

#### Diagnosis

1. History (high dose steroid long term / Addisonian)
2. Low BP, 20 mmHg lower than usual (systolic &lt;100 mmHg)

#### Dental Management

For dentistry, rare. Manage by:

- Calling 911/000
- Elevate legs, monitor BP
- Administer hydrocortisone 200 mg intramuscularly (or other routes/doses)
- Supportive (hydration, provide oxygen, glucose)

#### Prevention (from AD Australia)

**Minor surgery** — e.g. cataract surgery, hernia repairs, laparoscopy with local anaesthetic, endoscopy. Includes dental surgery &gt;1 hr and with local anaesthetic.

25 mg hydrocortisone IV or 20 mg oral with induction/immediately prior to onset of procedure.

#### Prevention in Dentistry

- Double dosage of steroid
- Avoid afternoon appointment in severe patients + stressful treatment (crisis can be fatal if occurring when sleeping)
- Avoid dentistry when patient has infection/fever/diarrhoea/sick

Therapeutic Guidelines Pg 151</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:55:53" confidence="8" anchor="25 mg hydrocortisone IV or 20 mg oral with induction/immediately prior to onset ">

&gt; [!note] Lecturer — Adrenal Prevention
&gt; Addison’s Disease Australia describes administering hydrocortisone or an oral steroid approximately one hour before dental surgery and local anaesthetic procedures.
&gt;
&gt; - This differs from dosing in the dental Therapeutic Guidelines, so the dental guideline should be followed.
&gt; - The standard approach discussed was to double the dose.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="33,694,419,885" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_9ca2c66156982e70.webp" caption="Minor surgery e.g. cataract surgery, hernia repairs, laparoscopy with local anaesthetic, endoscopy. Includes dental surgery &gt;1hr and with local anaesthetic. 25mg hydrocortisone IV or 20mg oral with induction/immediately prior to onset procedure">
        <description>A cropped section of a table detailing steroid coverage protocols for minor surgery. The left column defines the procedure category, listing examples such as cataract surgery, hernia repairs, and dental surgery over one hour with local anaesthetic. The right column specifies the corresponding dosage regimen: 25mg hydrocortisone IV or 20mg oral administered at induction or immediately prior to the onset of the procedure.</description>
      </img>
    </images>
  </page>
  <page number="22">
    <text># When to cover steroids?

Perioperative steroid is required to prevent an acute adrenal crisis in patients with HPA axis suppression. Patients taking

• ≥ 5 mg of prednisolone daily (or equivalent) for more than 1 to 4 weeks, or

• those who stopped a similar dose within the last 3 months

And for invasive or stressful procedures (e.g. GA, dental surgery or extraction, or if patient is highly anxious)

| Name | Equivalent dose in milligrams |
| :--- | :--- |
| Hydrocortisone | 20 |
| Prednisone | 5 |
| Prednisolone | 5 |
| Methylprednisolone | 4 |
| Dexamethasone | 0.75 |

**Therapeutic Guideline,**
**The Hospitalist**

![Name Equivalent dose in milligrams Hydrocortisone 20 Prednisone 5 Prednisolone 5 Methylprednisolone 4 Dexamethasone 0.75](L6 Endocrine notes_figures/img_35da8048490de11e.webp)</text>
    <formatted_text>Perioperative steroid is required to prevent an acute adrenal crisis in patients with HPA axis suppression. Patients taking:

- ≥ 5 mg of prednisolone daily (or equivalent) for more than 1 to 4 weeks, or
- those who stopped a similar dose within the last 3 months

And for invasive or stressful procedures (e.g. GA, dental surgery or extraction, or if patient is highly anxious).

#### Equivalent Steroid Doses

| Name | Equivalent dose in milligrams |
| :--- | :--- |
| Hydrocortisone | 20 |
| Prednisone | 5 |
| Prednisolone | 5 |
| Methylprednisolone | 4 |
| Dexamethasone | 0.75 |

Therapeutic Guideline; The Hospitalist</formatted_text>
    <audio_inserts count="1">
      <insert timestamp="00:58:36" confidence="8" anchor="And for invasive or stressful procedures (e.g. GA, dental surgery or extraction,">

&gt; [!note] Lecturer — Steroid Cover Indications
&gt; Steroid cover may also be considered for implants, long procedures such as crowns or bridges, and highly anxious patients.
&gt;
&gt; - The patient’s individual factors affect their endogenous steroid requirements.
</insert>
    </audio_inserts>
    <images>
      <img order="0" bbox="91,742,653,978" bbox_format="xyxy_norm_1000" bbox_origin="top_left" bbox_space="page" type="table" path="L6 Endocrine notes_figures/img_35da8048490de11e.webp" caption="Name Equivalent dose in milligrams Hydrocortisone 20 Prednisone 5 Prednisolone 5 Methylprednisolone 4 Dexamethasone 0.75">
        <description>Table: A two-column reference table listing five corticosteroid medications alongside their equivalent doses in milligrams. The data includes Hydrocortisone (20), Prednisone (5), Prednisolone (5), Methylprednisolone (4), and Dexamethasone (0.75).</description>
      </img>
    </images>
  </page>
  <page number="23">
    <text>&lt;h2&gt;Hypoglycaemia&lt;/h2&gt;

&lt;table&gt;
  &lt;tr&gt;
    &lt;td style=&quot;width: 50%; vertical-align: top; border: 1px solid black; padding: 10px;&quot;&gt;
      Patient can present with:&lt;br&gt;
      1. Neuroglycopenic - hunger, confusion, coma, seizure&lt;br&gt;
      2. Adrenergic - sweating, shaking, palpitations&lt;br&gt;
      3. unconscious (call 911, BLS)
    &lt;/td&gt;
    &lt;td style=&quot;width: 50%; vertical-align: top; border: 1px solid black; padding: 10px;&quot;&gt;
      Indicators for hypoglycaemia:&lt;br&gt;
      1. Blood sugar levels under 3.5mmol/L (usually)&lt;br&gt;
      2. Missed meals&lt;br&gt;
      3. Overdosed diabetic medication&lt;br&gt;
      4. Unplanned exercise (dental anxiety, rush for bus)
    &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td colspan=&quot;2&quot; style=&quot;border: 1px solid black; padding: 10px;&quot;&gt;
      For dentistry, it’s common to see this. If the person is conscious,&lt;br&gt;
      • give 20-25g of glucose or fast acting food/drink (fruit juice, jelly) followed by lower glycemic load carbohydrate meal. Sugary substitutes do not work well (coke zero, xylitol, saccharin)&lt;br&gt;
      • Observe.&lt;br&gt;
      • Taking blood sugar is helpful but not mandatory.&lt;br&gt;
      • Reschedule, and ensure someone goes home with them (escort)
    &lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;

**Therapeutic Guidelines Pg 178-179**</text>
    <formatted_text>#### Presentation

The patient can present with:

1. Neuroglycopenic — hunger, confusion, coma, seizure
2. Adrenergic — sweating, shaking, palpitations
3. Unconscious (call 911, BLS)

#### Indicators for Hypoglycaemia

1. Blood sugar levels under 3.5 mmol/L (usually)
2. Missed meals
3. Overdosed diabetic medication
4. Unplanned exercise (dental anxiety, rush for bus)

#### Dental Management

For dentistry, it's common to see this. If the person is conscious:

- Give 20–25 g of glucose or fast-acting food/drink (fruit juice, jelly) followed by lower glycemic load carbohydrate meal. Sugary substitutes do not work well (Coke Zero, xylitol, saccharin)
- Observe.
- Taking blood sugar is helpful but not mandatory.
- Reschedule, and ensure someone goes home with them (escort)

Therapeutic Guidelines Pg 178–179</formatted_text>
    <audio_inserts count="1">
      <insert confidence="1" anchor="- Reschedule, and ensure someone goes home with them (escort)

Therapeutic Guide">
- ==The patient should not drive while at risk of a further hypoglycaemic attack.==</insert>
    </audio_inserts>
  </page>
  <page number="24">
    <text>thank you and all the
**best**</text>
    <formatted_text>Thank you and all the best.</formatted_text>
  </page>
  <footnotes>[^1]: Original PDF page 1: [[L6 Endocrine notes.pdf#page=1|L6 Endocrine notes, p.1]]
[^2]: Original PDF page 2: [[L6 Endocrine notes.pdf#page=2|L6 Endocrine notes, p.2]]
[^3]: Original PDF page 3: [[L6 Endocrine notes.pdf#page=3|L6 Endocrine notes, p.3]]
[^4]: Original PDF page 4: [[L6 Endocrine notes.pdf#page=4|L6 Endocrine notes, p.4]]
[^5]: Original PDF page 5: [[L6 Endocrine notes.pdf#page=5|L6 Endocrine notes, p.5]]
[^6]: Original PDF page 6: [[L6 Endocrine notes.pdf#page=6|L6 Endocrine notes, p.6]]
[^7]: Original PDF page 7: [[L6 Endocrine notes.pdf#page=7|L6 Endocrine notes, p.7]]
[^8]: Original PDF page 8: [[L6 Endocrine notes.pdf#page=8|L6 Endocrine notes, p.8]]
[^9]: Original PDF page 9: [[L6 Endocrine notes.pdf#page=9|L6 Endocrine notes, p.9]]
[^10]: Original PDF page 10: [[L6 Endocrine notes.pdf#page=10|L6 Endocrine notes, p.10]]
[^11]: Original PDF page 11: [[L6 Endocrine notes.pdf#page=11|L6 Endocrine notes, p.11]]
[^12]: Original PDF page 12: [[L6 Endocrine notes.pdf#page=12|L6 Endocrine notes, p.12]]
[^13]: Original PDF page 13: [[L6 Endocrine notes.pdf#page=13|L6 Endocrine notes, p.13]]
[^14]: Original PDF page 14: [[L6 Endocrine notes.pdf#page=14|L6 Endocrine notes, p.14]]
[^15]: Original PDF page 15: [[L6 Endocrine notes.pdf#page=15|L6 Endocrine notes, p.15]]
[^16]: Original PDF page 16: [[L6 Endocrine notes.pdf#page=16|L6 Endocrine notes, p.16]]
[^17]: Original PDF page 17: [[L6 Endocrine notes.pdf#page=17|L6 Endocrine notes, p.17]]
[^18]: Original PDF page 18: [[L6 Endocrine notes.pdf#page=18|L6 Endocrine notes, p.18]]
[^19]: Original PDF page 19: [[L6 Endocrine notes.pdf#page=19|L6 Endocrine notes, p.19]]
[^20]: Original PDF page 20: [[L6 Endocrine notes.pdf#page=20|L6 Endocrine notes, p.20]]
[^21]: Original PDF page 21: [[L6 Endocrine notes.pdf#page=21|L6 Endocrine notes, p.21]]
[^22]: Original PDF page 22: [[L6 Endocrine notes.pdf#page=22|L6 Endocrine notes, p.22]]
[^23]: Original PDF page 23: [[L6 Endocrine notes.pdf#page=23|L6 Endocrine notes, p.23]]
[^24]: Original PDF page 24: [[L6 Endocrine notes.pdf#page=24|L6 Endocrine notes, p.24]]</footnotes>
</document>
